134 related articles for article (PubMed ID: 37353591)
1. Detection of the high-risk factors for synchronous bone metastasis in tonsillar squamous cell carcinoma.
Li Y; Hu C
Eur Arch Otorhinolaryngol; 2023 Oct; 280(10):4619-4625. PubMed ID: 37353591
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors for Synchronous Lung Metastasis in Squamous Cell Carcinoma of Hypopharynx.
Li Y; Hu C
Ear Nose Throat J; 2023 Nov; ():1455613231212052. PubMed ID: 37991192
[No Abstract] [Full Text] [Related]
3. Epidemiological and clinical characteristics of synchronous lung metastasis in major salivary gland mucoepidermoid carcinoma.
Li Y; Hu C
Eur Arch Otorhinolaryngol; 2023 Aug; 280(8):3835-3841. PubMed ID: 37100896
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and prognosis of synchronous distant metastatic tonsil squamous cell carcinomas.
Li Y; Hu C
Int J Med Sci; 2021; 18(2):528-533. PubMed ID: 33390822
[TBL] [Abstract][Full Text] [Related]
5. Survival in patients with carcinomas presenting with bone metastasis at diagnosis: a SEER population-based cohort study.
Younis MH; Fuentes-Rivera L; Summers S; Pretell-Mazzini J
Arch Orthop Trauma Surg; 2021 Mar; 141(3):367-373. PubMed ID: 32236712
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and prognostic impact of synchronous distant metastases in patients with hypopharynx squamous cell carcinomas: a SEER-based study.
Li Y; Ou X; Hu C
J Cancer; 2019; 10(3):620-626. PubMed ID: 30719159
[No Abstract] [Full Text] [Related]
7. Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: a population-based study.
Huang Z; Hu C; Liu K; Yuan L; Li Y; Zhao C; Hu C
BMC Cancer; 2020 Nov; 20(1):1145. PubMed ID: 33238981
[TBL] [Abstract][Full Text] [Related]
8. Patterns of bone metastases in newly diagnosed colorectal cancer: a real-world analysis in the SEER database.
Guo X; Zhang C; Ma W; Tian F; Xu G; Han X; Sun P; Baklaushev VP; Bryukhovetskiy AS; Wang G; Ma Y; Wang X
Int J Colorectal Dis; 2019 Mar; 34(3):533-543. PubMed ID: 30617414
[TBL] [Abstract][Full Text] [Related]
9. Risk Factors for Brain Metastases in Patients with Renal Cell Carcinoma.
Ke ZB; Chen SH; Chen YH; Wu YP; Lin F; Xue XY; Zheng QS; Xu N; Wei Y
Biomed Res Int; 2020; 2020():6836234. PubMed ID: 32219138
[TBL] [Abstract][Full Text] [Related]
10. Subsite variation in survival of oropharyngeal squamous cell carcinomas 2004 to 2011.
Platek ME; Jayaprakash V; Gupta V; Cohan DM; Hicks WL; Winslow TB; Platek AJ; Groman A; Dibaj S; Arshad H; Kuriakose MA; Warren GW; Singh AK
Laryngoscope; 2017 May; 127(5):1087-1092. PubMed ID: 27808409
[TBL] [Abstract][Full Text] [Related]
11. Advanced Hepatocellular Carcinoma with Bone Metastases: Prevalence, Associated Factors, and Survival Estimation.
Guo X; Xu Y; Wang X; Lin F; Wu H; Duan J; Xiong Y; Han X; Baklaushev VP; Xiong S; Chekhonin VP; Peltzer K; Wang G; Zhang C
Med Sci Monit; 2019 Feb; 25():1105-1112. PubMed ID: 30739123
[TBL] [Abstract][Full Text] [Related]
12. A clinical model to predict the risk of synchronous bone metastasis in newly diagnosed colorectal cancer: a population-based study.
Guan X; Ma CX; Quan JC; Li S; Zhao ZX; Chen HP; Yang M; Liu Z; Jiang Z; Wang XS
BMC Cancer; 2019 Jul; 19(1):704. PubMed ID: 31315606
[TBL] [Abstract][Full Text] [Related]
13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
14. LONG-TERM OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA AND BONE METASTASES.
Slook O; Levy S; Slutzky-Shraga I; Tsvetov G; Robenshtok E; Shimon I; Benbassat C; Hirsch D
Endocr Pract; 2019 May; 25(5):427-437. PubMed ID: 30657361
[No Abstract] [Full Text] [Related]
15. Clear cell renal cell carcinoma bone metastasis: What should be considered in prognostic evaluation.
Huang Z; Du Y; Zhang X; Liu H; Liu S; Xu T
Eur J Surg Oncol; 2019 Jul; 45(7):1246-1252. PubMed ID: 30760414
[TBL] [Abstract][Full Text] [Related]
16. Impact of homogeneous and heterogeneous risk factors on the incidence and prognosis of brain metastases in patients with hepatocellular carcinoma.
Lin X; Zhang P; Huang R; Huang Y; Sun J; Zheng H; Tian X; Wang X
Ann Palliat Med; 2020 Sep; 9(5):2654-2667. PubMed ID: 32921091
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impacts of extracranial metastasis on non-small cell lung cancer with brain metastasis: A retrospective study based on surveillance, epidemiology, and end results database.
Wang M; Wu Q; Zhang J; Qin G; Yang T; Liu Y; Wang X; Zhang B; Wei Y
Cancer Med; 2021 Jan; 10(2):471-482. PubMed ID: 33320433
[TBL] [Abstract][Full Text] [Related]
18. Impact of the homogeneous and heterogeneous risk factors on the incidence and survival outcome of bone metastasis in NSCLC patients.
Song Q; Shang J; Zhang C; Zhang L; Wu X
J Cancer Res Clin Oncol; 2019 Mar; 145(3):737-746. PubMed ID: 30603904
[TBL] [Abstract][Full Text] [Related]
19. Predictors of prognosis of synchronous brain metastases in small-cell lung cancer patients.
Reddy SP; Dowell JE; Pan E
Clin Exp Metastasis; 2020 Aug; 37(4):531-539. PubMed ID: 32500410
[TBL] [Abstract][Full Text] [Related]
20. Risk factors and nomogram for newly diagnosis of bone metastasis in bladder cancer: A SEER-based study.
Fan Z; Huang Z; Hu C; Tong Y; Zhao C
Medicine (Baltimore); 2020 Oct; 99(42):e22675. PubMed ID: 33080711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
